A randomized clinical trial of antibiotic treatment duration in preterm premature rupture of membranes: 7 days vs until delivery

Citations

WEB OF SCIENCE

7
Citations

SCOPUS

8

초록

BACKGROUND: Antibiotic treatment in preterm premature rupture of membranes can prolong the interval from membrane rupture to delivery and improve neonatal outcomes. However, the duration of antibiotic treat-ment for preterm premature rupture of membranes has been rarely com-pared in prospective studies.OBJECTIVE: This study aimed to investigate the optimal duration of antibiotic treatment for premature rupture of membranes. We performed a randomized controlled trial comparing neonatal morbidity and infantile neurologic outcomes between 2 groups of patients with preterm prema-ture rupture of membranes who received antibiotic treatment for 7 days or until delivery, respectively.STUDY DESIGN: This prospective randomized study included patients who were diagnosed with preterm premature rupture of membranes between 22+0 weeks and 33+6 weeks of gestation. The enrolled patients were randomly assigned to receive intravenous cefazolin (1 g dosage every 12 hours) and oral clarithromycin (500 mg dosage every 12 hours) either for 7 days or until delivery. The study protocol was registered at Clinical-Trials.gov under identifier NCT01503606. The primary outcome was a neonatal composite morbidity, and the secondary outcome was neurologic outcomes at 12 months of corrected age. We enrolled 151 patients and allocated 75 and 76 of them to the 7-day and until-delivery groups, respectively. Analysis was done by per protocol.RESULTS: After excluding cases lost to follow-up and those with proto-col violations, 63 (7-day regimen) and 61 (until-delivery regimen) patients with preterm premature rupture of membranes and their babies were compared. There was no significant difference in the pregnancy out-comes, including gestational age at delivery and the interval from rupture of membranes to delivery, between the 2 groups. Among the neonatal out-comes, bronchopulmonary dysplasia, intraventricular hemorrhage, retinop-athy of prematurity, necrotizing enterocolitis, and proven neonatal sepsis did not differ between the groups. However, the rates of respiratory dis-tress syndrome (32.8% vs 50.8%; P=.039) and composite neonatal mor-bidities (34.4% vs 53.9%; P=.026) were lower in the until-delivery group than in the 7-day group. This difference remained statistically significant after a multivariable analysis adjusting for maternal age, twin pregnancy, antenatal corticosteroids treatment, gestational age at delivery, interval from rupture of membranes to delivery, and clinical chorioamnionitis. Infantile neurologic outcomes were evaluated in 71.4% of the babies dis-charged alive and did not differ between the groups.CONCLUSION: Overall, the until-delivery regimen of cefazolin and clarithromycin in preterm premature rupture of membranes led to a lower incidence of composite neonatal morbidity and respiratory dis-tress syndrome than the 7-day regimen, and both regimens otherwise showed similar individual neonatal morbidities and infantile neurologic outcomes.

키워드

antibiotics; duration of treatment; neonatal morbidity; pre-term premature rupture of membranes; respiratory distress syndrome; INTRAAMNIOTIC INFLAMMATION; NEONATAL MORBIDITY; MYCOPLASMA-HOMINIS; PRELABOR RUPTURE; FOLLOW-UP; CLARITHROMYCIN; OUTCOMES; THERAPY; CHORIOAMNIONITIS; SUSCEPTIBILITY
제목
A randomized clinical trial of antibiotic treatment duration in preterm premature rupture of membranes: 7 days vs until delivery
저자
Sung, Ji-Hee; Kim, Jin-Ha; Kim, Yejin; Choi, Yun-Sun; Hong, Siryeon; Choi, Suk-Joo; Kim, Jung -Sun; Roh, Cheong-Rae; Oh, Soo-young
DOI
10.1016/j.ajogmf.2023.100886
발행일
2023-04
유형
Article
저널명
American Journal of Obstetrics and Gynecology MFM
권
5
호
4